Prelief Supplement Scores OTC Drug Comparison, But Misses On Acid Removal – NAD
This article was originally published in The Rose Sheet
Executive Summary
DSE Healthcare substantiates online claims that the Prelief supplement “does not predispose” to problems associated with use of PPIs and beta blockers, NAD says, but advises the firm to discontinue broad acid-removal and symptom-cessation claims.
You may also be interested in...
FTC Updates Endorsement Guide Resource: 'What People Are Asking'
Agency's updated FAQ web page tackles questions stakeholders have been asking in recent years about its Endorsement Guide, including the appropriate way to provide disclosures on social-media platforms and the responsibilities of companies using large networks of bloggers and other influencers to promote products.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.